Alpha Tau Medical Ltd.

NASDAQ:DRTS

Biotechnology

Healthcare
$12.01 +0.42%

+$0.04 today

Market cap
$1.11B
Beta
1.20
P/E (TTM)
-15.2
EPS (TTM)
-$0.63
52W Low $2.85High $11.62

Volume 0.64M

Average 0.69M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$26.68M

FY 2025 · Annual

Investing Cash Flow

-$20.59M

FY 2025 · Annual

Financing Cash Flow

$45.77M

FY 2025 · Annual

+182972.0% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.27M)(33.76M)(29.16M)(31.75M)(42.63M)
Depreciation & Amortization776K979K1.07M1.1M1.23M
Deferred Income Tax00000
Stock-Based Compensation812K6.75M7.93M9.92M0
Change in Working Capital585K(307K)2.49M1.17M2.29M
Accounts Receivables00000
Inventory00000
Accounts Payables239K220K1.14M965K337K
Other Working Capital346K(527K)1.35M203K1.95M
Other Non-Cash Items13.29M2.46M(293K)(219K)12.42M
Operating Cash Flow(11.81M)(23.88M)(17.96M)(19.78M)(26.68M)
Capital Expenditures(2.93M)(904K)(6.4M)(2.24M)(6.08M)
Acquisitions (Net)00000
Purchases of Investments000(125.08M)(70.49M)
Sales of Investments000148.19M55.98M
Other Investing Activities22.2M(89.03M)25.08M(103K)0
Investing Cash Flow19.27M(89.94M)18.68M20.77M(20.59M)
Debt Repayment00000
Common Stock Issued111K3.36M49K25K45.77M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities093.54M5.25M00
Financing Cash Flow111K96.91M5.3M25K45.77M
Effect of Forex Changes108K(258K)3.1M160K501K
Net Change in Cash7.68M(17.17M)9.12M1.17M(1M)
Free Cash Flow(14.74M)(24.78M)(24.36M)(22.02M)(32.76M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$42.6M
+ D&A$1.2M
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$2.3M
+ Other Non-Cash$12.4M
= Operating Cash Flow-$26.7M
- Capex-$6.1M
= Free Cash Flow-$32.8M

Analysis

FY2025 free cash flow is -$32.8M. FCF conversion is 76.8% of net income. Operating cash flow was -$26.7M, with capex of -$6.1M. The largest bridge item is Other Non-Cash at $12.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
6-K6-K filingOct 29, 2026
6-K6-K filingOct 22, 2026
6-K6-K filingOct 19, 2026
6-K6-K filingAug 31, 2026

Does DRTS generate free cash flow?

Alpha Tau Medical Ltd. (DRTS) generated -$32.76M of free cash flow in fiscal 2025.

How much operating cash flow does DRTS produce?

Operating cash flow was -$26.68M, before capital expenditures of $6.08M.